Referenser

Referenser
1. Livsmedelsverket, SLVFS 2000:15, bilaga 1, kategori 3. Betaglucare omfattas av regelverket LIVSFS 2008:3, Livsmedelsverkets föreskrift om livsmedel för speciella medicinska ändamål.
2. FDA 1997, SNF 2001, EFSA 2009.
3. Marlett J A, et al. Mechanism of serum cholesterol reduction by oat bran. Hepathology 20:1450,1994.
4. Ripsin C M, et al. Oat products and lipid lowering: A metaanalysis. JAMA 267(24):3317, 1992.
5. Rosengren. Incitament, vol 19, 2010, s 437-441.
6. Kabir M, et al. Four-week low glycemic index breakfast with a modest amount of soluble fibres in type 2 diabetic men. Metabolism, 51:819, 2002.
7. Battilana P, et al. Mechanism of action of betaglucan in postprandial glucose metabolism. Eur J Clin 55:327,2001
8. Granfeldt Y, et al. Muesli with 4g oat betaglucans lowes glucose and insulin responses after a bread meal in healthy subjects. Eur J of Clin Nutr (2008)62, 600-607.
9. Wolever T, et al. Physicochemical properties of oat betaglucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr 2010; 92: 723-32.
10. Socialstyrelsen, Diabetesriktlinjer 1999. Handlingsprogram för Diabetes Mellitus: Nordöstra Skåne 2008, Landstinget i Östergötland 2007 (25 april).
11. Portföljstudien, presenterad okt 2010, Professor Inger Björck, Lunds Universitet

Övrig dokumentation av vikt:
- Tosh S, et al. Glycemic Response to Oat Bran Muffins Treated to Vary Molecular Weight of betaglucan. Cereal Chem. 85(2):211-217.
- Kvalitetssäkringsstudie: BIP - Betaglucare i Praktiken. Utförd 2008. För ytterligare information/underlag kontakta Prorsum Healthcare AB, info@prorsum.se.
- Marlett J A. Comparision of dietary fiber and selected nutrients compositions of oat and other grain fractions. Pages 49-82 in: Oat Bran. P J Wood, ed. American Association of Cereal Chemist, St.Paul, MN, 1993.
- Pick, M E, et al. Oat bran bread products improve longterm control of diabetes. A pilot study. J of Am Diet Assoc. 96:1254, 1996.